Stimulation of Xenopus P2Y1 receptor activates CFTR in A6 cells

Pflugers Arch. 2004 Oct;449(1):66-75. doi: 10.1007/s00424-004-1293-2.

Abstract

Nucleotide binding to purinergic P2Y receptors contributes to the regulation of a variety of physiological functions in renal epithelial cells. Here, we investigate the regulatory mechanism of the P2Y1 receptor agonist 2-methylthioadenosine diphosphate (2-MeSADP) on Cl- transport in A6 cells, a commonly used model of the distal section of the Xenopus laevis nephron. Protein and mRNA expression analysis together with functional measurements demonstrated the basolateral location of the Xenopus P2Y1 receptor. 2-MeSADP increased intracellular [Ca2+] and cAMP and Cl- efflux, responses that were all inhibited by the specific P2Y1 receptor antagonist MRS 2179. Cl- efflux was also inhibited by the cystic fibrosis transmembrane conductance regulator (CFTR) blocker glibenclamide. Inhibition of either protein kinase A (PKA) or the binding between A-kinase-anchoring proteins (AKAPs) and the regulatory PKA RII subunit blocked the 2-MeSADP-induced activation of CFTR, suggesting that PKA mediates P2Y1 receptor regulation of CFTR through one or more AKAPs. Further, the truncation of the PDZ1 domain of the scaffolding protein Na+/H+ exchanger regulatory factor-2 (NHERF-2) inhibited 2-MeSADP-dependent stimulation of Cl- efflux, suggesting the involvement of this scaffolding protein. Activation or inhibition of PKC had no effect per se on basal Cl- efflux but potentiated or reduced the 2-MeSADP-dependent stimulation of Cl- efflux, respectively. These data suggest that the X laevis P2Y1 receptor in A6 cells can increase both cAMP/PKA and Ca2+/PKC intracellular levels and that the PKC pathway is involved in CFTR activation via potentiation of the PKA pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives
  • Adenosine Diphosphate / metabolism
  • Animals
  • Calcium / metabolism
  • Cell Line
  • Chlorides / metabolism
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis Transmembrane Conductance Regulator / metabolism*
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism*
  • Glyburide / metabolism
  • Indomethacin / metabolism
  • Isoquinolines / metabolism
  • Kidney Tubules / cytology
  • Phosphoproteins / metabolism*
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / metabolism*
  • Receptors, Purinergic P2Y1
  • Sodium-Hydrogen Exchangers
  • Sulfonamides / metabolism
  • Thionucleotides / metabolism
  • Xenopus laevis

Substances

  • Chlorides
  • Isoquinolines
  • N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate
  • Phosphoproteins
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y1
  • Sodium-Hydrogen Exchangers
  • Sulfonamides
  • Thionucleotides
  • sodium-hydrogen exchanger regulatory factor
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • methylthio-ADP
  • Adenosine Diphosphate
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Glyburide
  • Calcium
  • Indomethacin